| Year |
Citation |
Score |
| 2018 |
Rahman MS, Fernando S, Ross B, Wu J, Qin W. Endoglucanase (EG) Activity Assays. Methods in Molecular Biology (Clifton, N.J.). 1796: 169-183. PMID 29856054 DOI: 10.1007/978-1-4939-7877-9_13 |
0.315 |
|
| 2017 |
Ross BM. Methylnicotinate stimulated prostaglandin synthesis in patients with schizophrenia: A preliminary investigation. Prostaglandins, Leukotrienes, and Essential Fatty Acids. PMID 28552466 DOI: 10.1016/j.plefa.2017.05.002 |
0.331 |
|
| 2015 |
Ross BM, Babay S, Malik I. Brain and Liver Headspace Aldehyde Concentration Following Dietary Supplementation with n-3 Polyunsaturated Fatty Acids. Lipids. 50: 1123-31. PMID 26358696 DOI: 10.1007/s11745-015-4063-3 |
0.303 |
|
| 2014 |
Ross BM, Glen I. The Relationship between Impaired Methylnicotinate Response and Oxidative Stress in Schizophrenia Open Journal of Psychiatry. 4: 141-146. DOI: 10.4236/Ojpsych.2014.42018 |
0.347 |
|
| 2011 |
Ross BM, Maxwell R, Glen I. Increased breath ethane levels in medicated patients with schizophrenia and bipolar disorder are unrelated to erythrocyte omega-3 fatty acid abundance. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 35: 446-53. PMID 21115087 DOI: 10.1016/j.pnpbp.2010.11.032 |
0.351 |
|
| 2011 |
Ross BM, Shah S, Peet M. Increased breath ethane and pentane concentrations in currently unmedicated patients with schizophrenia Open Journal of Psychiatry. 1: 1-7. DOI: 10.4236/Ojpsych.2011.11001 |
0.326 |
|
| 2008 |
Puri BK, Counsell SJ, Ross BM, Hamilton G, Bustos MG, Treasaden IH. Evidence from in vivo 31-phosphorus magnetic resonance spectroscopy phosphodiesters that exhaled ethane is a biomarker of cerebral n-3 polyunsaturated fatty acid peroxidation in humans. Bmc Psychiatry. 8: S2. PMID 18433512 DOI: 10.1186/1471-244X-8-S1-S2 |
0.332 |
|
| 2008 |
Puri BK, Ross BM, Treasaden IH. Increased levels of ethane, a non-invasive, quantitative, direct marker of n-3 lipid peroxidation, in the breath of patients with schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 32: 858-62. PMID 18262322 DOI: 10.1016/j.pnpbp.2008.01.001 |
0.331 |
|
| 2006 |
Ross BM, Hughes B, Kish SJ, Warsh JJ. Serum calcium-independent phospholipase A2 activity in bipolar affective disorder. Bipolar Disorders. 8: 265-70. PMID 16696828 DOI: 10.1111/J.1399-5618.2006.00299.X |
0.374 |
|
| 2004 |
Ross BM, Hughes B, Turenne S, Seeman M, Warsh JJ. Reduced vasodilatory response to methylnicotinate in schizophrenia as assessed by laser Doppler flowmetry. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 14: 191-7. PMID 15056478 DOI: 10.1016/S0924-977X(03)00145-7 |
0.321 |
|
| 2004 |
Macdonald DJ, Boyle RM, Glen AC, Ross BM, Glen AI, Ward PE, McKinney SB, Peterkin MA. The investigation of cytosolic phospholipase A2 using ELISA. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 70: 377-81. PMID 15041030 DOI: 10.1016/j.plefa.2003.12.013 |
0.301 |
|
| 2003 |
Ross BM. Phospholipid and eicosanoid signaling disturbances in schizophrenia. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 69: 407-12. PMID 14623494 DOI: 10.1016/j.plefa.2003.08.012 |
0.351 |
|
| 2003 |
Fox H, Ross BM, Tocher D, Horrobin D, Glen I, St Clair D. Degradation of specific polyunsaturated fatty acids in red blood cells stored at -20 degrees C proceeds faster in patients with schizophrenia when compared with healthy controls. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 69: 291-7. PMID 14580362 DOI: 10.1016/S0952-3278(03)00084-X |
0.35 |
|
| 2003 |
Maclean R, Ward PE, Glen I, Roberts SJ, Ross BM. On the relationship between methylnicotinate-induced skin flush and fatty acids levels in acute psychosis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 27: 927-33. PMID 14499309 DOI: 10.1016/S0278-5846(03)00152-0 |
0.338 |
|
| 2001 |
Ross BM, Mamalias N, Moszczynska A, Rajput AH, Kish SJ. Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease. Neuroscience. 102: 899-904. PMID 11182251 DOI: 10.1016/S0306-4522(00)00501-7 |
0.409 |
|
| 2000 |
Ross BM, Eder K, Moszczynska A, Mamalias N, Lamarche J, Ang L, Pandolfo M, Rouleau G, Kirchgessner M, Kish SJ. Abnormal activity of membrane phospholipid synthetic enzymes in the brain of patients with Friedreich's ataxia and spinocerebellar atrophy type-1. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 294-300. PMID 10752579 DOI: 10.1002/1531-8257(200003)15:2<294::Aid-Mds1013>3.0.Co;2-D |
0.4 |
|
| 1999 |
Hudson C, Gotowiec A, Seeman M, Warsh J, Ross BM. Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia. Biological Psychiatry. 46: 401-5. PMID 10435206 DOI: 10.1016/S0006-3223(99)00010-4 |
0.373 |
|
| 1999 |
Fallbrook A, Turenne SD, Mamalias N, Kish SJ, Ross BM. Phosphatidylcholine and phosphatidylethanolamine metabolites may regulate brain phospholipid catabolism via inhibition of lysophospholipase activity. Brain Research. 834: 207-10. PMID 10407117 DOI: 10.1016/S0006-8993(99)01570-X |
0.402 |
|
| 1999 |
Ross BM, Turenne S, Moszczynska A, Warsh JJ, Kish SJ. Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia. Brain Research. 821: 407-13. PMID 10064828 DOI: 10.1016/S0006-8993(99)01123-3 |
0.403 |
|
| 1998 |
Kish SJ, Lopes-Cendes I, Guttman M, Furukawa Y, Pandolfo M, Rouleau GA, Ross BM, Nance M, Schut L, Ang L, DiStefano L. Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders. Archives of Neurology. 55: 1299-304. PMID 9779656 DOI: 10.1001/Archneur.55.10.1299 |
0.319 |
|
| 1998 |
Ross BM, Moszczynska A, Erlich J, Kish SJ. Low activity of key phospholipid catabolic and anabolic enzymes in human substantia nigra: possible implications for Parkinson's disease. Neuroscience. 83: 791-8. PMID 9483562 DOI: 10.1016/S0306-4522(97)00454-5 |
0.695 |
|
| 1998 |
Ross BM, Moszczynska A, Erlich J, Kish SJ. Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity. Journal of Neurochemistry. 70: 786-93. PMID 9453575 DOI: 10.1046/J.1471-4159.1998.70020786.X |
0.692 |
|
| 1997 |
Ross BM, Hudson C, Erlich J, Warsh JJ, Kish SJ. Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2. Archives of General Psychiatry. 54: 487-94. PMID 9152103 DOI: 10.1001/Archpsyc.1997.01830170113015 |
0.695 |
|
| 1997 |
Ross BM, Moszczynska A, Blusztajn JK, Sherwin A, Lozano A, Kish SJ. Phospholipid biosynthetic enzymes in human brain. Lipids. 32: 351-8. PMID 9113621 DOI: 10.1007/S11745-997-0044-X |
0.368 |
|
| 1996 |
Ross BM, Moszczynska A, Kalasinsky K, Kish SJ. Phospholipase A2 activity is selectively decreased in the striatum of chronic cocaine users. Journal of Neurochemistry. 67: 2620-3. PMID 8931499 DOI: 10.1046/J.1471-4159.1996.67062620.X |
0.325 |
|
| 1995 |
Ross BM, Sherwin AL, Kish SJ. Multiple forms of the enzyme glycerophosphodiesterase are present in human brain. Lipids. 30: 1075-81. PMID 8614297 DOI: 10.1007/Bf02536607 |
0.36 |
|
| 1995 |
Ross BM, Kim DK, Bonventre JV, Kish SJ. Characterization of a novel phospholipase A2 activity in human brain. Journal of Neurochemistry. 64: 2213-21. PMID 7722506 DOI: 10.1046/J.1471-4159.1995.64052213.X |
0.414 |
|
| 1994 |
Ross BM, Kish SJ. Characterization of lysophospholipid metabolizing enzymes in human brain. Journal of Neurochemistry. 63: 1839-48. PMID 7931340 DOI: 10.1046/J.1471-4159.1994.63051839.X |
0.398 |
|
| 1993 |
Ross BM, McLaughlin M, Roberts M, Milligan G, McCulloch J, Knowler JT. Alterations in the activity of adenylate cyclase and high affinity GTPase in Alzheimer's disease. Brain Research. 622: 35-42. PMID 8242380 DOI: 10.1016/0006-8993(93)90798-R |
0.342 |
|
| Show low-probability matches. |